Hudson Bay Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-85,000
| Closed | -$2.01M | – | 836 |
|
|
2023
Q4 | $2.01M | Buy |
85,000
+55,000
| +183% | +$1.3M | 0.01% | 391 |
|
|
2023
Q3 | $447K | Buy |
+30,000
| New | +$447K | ﹤0.01% | 521 |
|
|
2023
Q2 | – | Sell |
-266,400
| Closed | -$2.32M | – | 954 |
|
|
2023
Q1 | $2.32M | Sell |
266,400
-431,100
| -62% | -$3.76M | 0.02% | 463 |
|
|
2022
Q4 | $4.37M | Sell |
697,500
-627,500
| -47% | -$3.93M | 0.04% | 363 |
|
|
2022
Q3 | $4.64M | Sell |
1,325,000
-174,900
| -12% | -$612K | 0.04% | 417 |
|
|
2022
Q2 | $4.43M | Buy |
1,499,900
+714,900
| +91% | +$2.11M | 0.03% | 450 |
|
|
2022
Q1 | $2.44M | Buy |
785,000
+135,000
| +21% | +$420K | 0.03% | 642 |
|
|
2021
Q4 | $2.2M | Buy |
650,000
+269,948
| +71% | +$912K | 0.02% | 636 |
|
|
2021
Q3 | $1.39M | Buy |
380,052
+80,052
| +27% | +$292K | 0.02% | 674 |
|
|
2021
Q2 | $1.31M | Buy |
300,000
+95,000
| +46% | +$414K | 0.02% | 671 |
|
|
2021
Q1 | $931K | Buy |
205,000
+112,241
| +121% | +$510K | 0.01% | 682 |
|
|
2020
Q4 | $532K | Buy |
+92,759
| New | +$532K | 0.01% | 481 |
|
|
2020
Q3 | – | Sell |
-335,000
| Closed | -$1.17M | – | 639 |
|
|
2020
Q2 | $1.17M | Buy |
335,000
+120,000
| +56% | +$419K | 0.02% | 355 |
|
|
2020
Q1 | $318K | Sell |
215,000
-110,000
| -34% | -$163K | 0.01% | 378 |
|
|
2019
Q4 | $637K | Buy |
+325,000
| New | +$637K | 0.01% | 316 |
|
|
2019
Q3 | – | Sell |
-14,000
| Closed | -$100K | – | 466 |
|
|
2019
Q2 | $100K | Buy |
+14,000
| New | +$100K | ﹤0.01% | 345 |
|